Literature DB >> 2014508

Plasma tumour necrosis factor alpha in cystic fibrosis.

D Norman1, J S Elborn, S M Cordon, R J Rayner, M S Wiseman, E J Hiller, D J Shale.   

Abstract

Plasma tumour necrosis factor alpha (alpha) concentration is increased in acute Gram negative sepsis, but the effect of chronic infection on plasma concentrations is unknown. A study was carried out in patients with cystic fibrosis to determine the effect of chronic lung infection with Pseudomonas aeruginosa on the plasma concentration of tumour necrosis factor and two other indicators of the inflammatory response, circulating C reactive protein and neutrophil elastase-alpha 1 antiproteinase complex (elastase complex). The concentration of immunoreactive tumour necrosis factor in plasma was greater than the upper 95% confidence interval for healthy subjects (2.6 U/ml) on 129 out of 189 occasions in 14 patients observed for about a year. The increase in tumour necrosis factor was associated with increased circulating C reactive protein and elastase complex. Twelve patients with an exacerbation of respiratory symptoms were studied before and after two weeks' treatment with anti-pseudomonal antibiotics. All three indicators of the inflammatory response fell after treatment, though median tumour necrosis factor (4.8 U/ml) and elastase complex (0.41 microgram/ml) concentrations remained above the upper limits for healthy subjects. During a period of clinical stability plasma tumour necrosis factor was increased in 10 of the 12 patients, elastase complex was increased in 10 of the 12, and C reactive protein was increased in seven. Increased plasma immunoreactive tumour necrosis factor was a feature of the near continuous inflammatory response to chronic P aeruginosa infection in cystic fibrosis and may be a factor contributing to the progressive lung destruction seen in this disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014508      PMCID: PMC462953          DOI: 10.1136/thx.46.2.91

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

Review 1.  The role of immune complexes in the pathogenesis of bacterial infections.

Authors:  N Høiby; G Döring; P O Schiøtz
Journal:  Annu Rev Microbiol       Date:  1986       Impact factor: 15.500

Review 2.  Cytokines as inflammatory mediators.

Authors:  M E Billingham
Journal:  Br Med Bull       Date:  1987-04       Impact factor: 4.291

3.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

4.  Diagnostic criteria for adult respiratory distress syndrome: time for reappraisal.

Authors:  G M Rocker; M S Wiseman; D Pearson; D J Shale
Journal:  Lancet       Date:  1989-01-21       Impact factor: 79.321

5.  Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis.

Authors:  S Suter; U B Schaad; P Roux-Lombard; E Girardin; G Grau; J M Dayer
Journal:  Am Rev Respir Dis       Date:  1989-12

6.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

7.  Detection of circulating tumor necrosis factor after endotoxin administration.

Authors:  H R Michie; K R Manogue; D R Spriggs; A Revhaug; S O'Dwyer; C A Dinarello; A Cerami; S M Wolff; D W Wilmore
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

8.  Cytokine appearance in human endotoxemia and primate bacteremia.

Authors:  D G Hesse; K J Tracey; Y Fong; K R Manogue; M A Palladino; A Cerami; G T Shires; S F Lowry
Journal:  Surg Gynecol Obstet       Date:  1988-02

9.  Tumor necrosis factor and disease severity in children with falciparum malaria.

Authors:  G E Grau; T E Taylor; M E Molyneux; J J Wirima; P Vassalli; M Hommel; P H Lambert
Journal:  N Engl J Med       Date:  1989-06-15       Impact factor: 91.245

10.  The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.

Authors:  A Waage; P Brandtzaeg; A Halstensen; P Kierulf; T Espevik
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  22 in total

1.  TNF-alpha promoter polymorphism in relation to TNF-alpha production and clinical status in cystic fibrosis.

Authors:  Sabina Schmitt-Grohé; Frank Stüber; Malte Book; Joachim Bargon; Thomas O Wagner; Christian Naujoks; Ralf Schubert; Michael J Lentze; Stefan Zielen
Journal:  Lung       Date:  2006 Mar-Apr       Impact factor: 2.584

Review 2.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

3.  Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs.

Authors:  J S Elborn; R J Prescott; B H Stack; M C Goodchild; J Bates; C Pantin; N Ali; D J Shale; M Crane
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

Review 4.  Chronic suppurative lung disease with associated vasculitis.

Authors:  I N Bruce; J A McAteer; P V Gardiner; R J McFarland; J M Sloan; A L Bell
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

5.  Resting energy expenditure and oxygen cost of breathing in patients with cystic fibrosis.

Authors:  S C Bell; M J Saunders; J S Elborn; D J Shale
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

Review 6.  Monitoring inflammation in CF. Cytokines.

Authors:  Scott D Sagel; Frank J Accurso
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

Review 7.  New perspectives in understanding and management of the respiratory disease in cystic fibrosis.

Authors:  S Suter
Journal:  Eur J Pediatr       Date:  1994-03       Impact factor: 3.183

Review 8.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

9.  Bone mineral density and body composition in adult patients with cystic fibrosis.

Authors:  A B Grey; R W Ames; R D Matthews; I R Reid
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

10.  Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis.

Authors:  P Greally; M J Hussein; A J Cook; A P Sampson; P J Piper; J F Price
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.